COMMUNIQUÉS West-GlobeNewswire

Harvard Bioscience Subsidiary Data Sciences International Launches Two Telemetry Implants to Enhance Neuroscience Research

01/05/2018 - 22:30

PhysioTel™ Digital L03 and L04 Designed to Improve Animal Welfare in Large Animal Models ST. PAUL, Minn. and HOLLISTON, Mass., May 01, 2018 (GLOBE NEWSWIRE) -- Data Sciences International (DSI), a subsidiary of Harvard [...]

Assure Holdings Corp. Announces Update

01/05/2018 - 22:30

PARKER, Colo., May 01, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSXV:IOM) (OTCQB:ARHH) is announcing that the Company has applied for and received a Management Cease Trade Order (“ [...]

Teligent, Inc. to Present at Deutsche Bank’s 43rd Annual Health Care Conference on Tuesday May 8, 2018

01/05/2018 - 22:30

BUENA, N.J., May 01, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT ), a New Jersey based specialty generic pharmaceutical company, will be presenting at Deutsche Bank’s 43 rd Annual Health Care Conference. The [...]

Avivagen Announces its Attendance at the Bloom Burton & Co. Healthcare Investor Conference

01/05/2018 - 22:30

OTTAWA, May 01, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, [...]

Zafgen to Host Conference Call to Discuss First Quarter 2018 Financial Results

01/05/2018 - 22:30

BOSTON, May 01, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq: ZFGN ), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients [...]

OpGen Announces Date of First Quarter 2018 Financial Results Conference Call

01/05/2018 - 22:30

GAITHERSBURG, Md., May 01, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN ) announced today that the Company will report financial results for the three months ended March 31, 2018 after close of the U.S. financial [...]

Kymriah® (tisagenlecleucel), first-in-class CAR-T therapy from Novartis, receives second FDA approval to treat appropriate r/r patients with large B-cell lymphoma

01/05/2018 - 22:27

Kymriah demonstrated an overall response rate of 50%, with median duration of response not yet reached at the time of data cut-off, indicating sustainability of response[1] Kymriah is the only CAR-T therapy FDA-approved [...]

Capital Senior Living Corporation Reports First Quarter 2018 Results

01/05/2018 - 22:15

DALLAS, May 01, 2018 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (the “Company”) (NYSE: CSU ), one of the nation’s largest operators of senior housing communities, today announced operating and financial [...]

TESARO Announces Participation in Two Investor Conferences

01/05/2018 - 22:15

WALTHAM, Mass., May 01, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO ), an oncology-focused biopharmaceutical company, today announced its participation in two upcoming investor conferences. The two conferences [...]

Prothena to Report First Quarter 2018 Financial Results on May 8

01/05/2018 - 22:05

DUBLIN, Ireland, May 01, 2018 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq: PRTA ), a clinical-stage biotechnology company focused on the discovery and development of novel therapies in the neuroscience and [...]

resTORbio to Present at the Deutsche Bank 43rd Annual Health Care Conference

01/05/2018 - 22:05

BOSTON, May 01, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ: TORC ), a clinical-stage biopharmaceutical company focused on helping people live healthier longer through the development and commercialization of novel [...]

K2M Group Holdings, Inc. Reports First Quarter 2018 Financial Results and Updates Fiscal Year 2018 Outlook

01/05/2018 - 22:05

LEESBURG, Va., May 01, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (Nasdaq: KTWO ) (the “Company” or “K2M”), a global leader of complex spine and minimally invasive solutions focused on achieving three-dimensional [...]

Pernix Therapeutics to Report First Quarter 2018 Financial Results on Thursday, May 10

01/05/2018 - 22:05

MORRISTOWN, N.J., May 01, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX ), a specialty pharmaceutical company, announced today that the Company will report financial results for the first [...]

Sunesis Pharmaceuticals to Host Conference Call on May 8th to Discuss First Quarter 2018 Financial Results and Recent Highlights

01/05/2018 - 22:05

SOUTH SAN FRANCISCO, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS ) today announced that it will host a conference call on Tuesday, May 8 th , 2018 at 4:30 p.m. Eastern Time to [...]

Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call

01/05/2018 - 22:05

MENLO PARK, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT ) today announced it will report first quarter financial results and provide a corporate update on May 8, 2018. The [...]

GenMark Diagnostics Reports First Quarter 2018 Results

01/05/2018 - 22:05

CARLSBAD, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK ), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the [...]

SIGA Technologies Announces Favorable Outcome of Advisory Committee In Support of TPOXX®

01/05/2018 - 22:03

NEW YORK, May 01, 2018 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA ), a health security company specializing in the development and commercialization of solutions for serious unmet medical needs and [...]

Galapagos and MorphoSys announce initiation of the IGUANA Phase 2 clinical trial with MOR106 in atopic dermatitis patients

01/05/2018 - 22:02

Mechelen, Belgium and Planegg/Munich, Germany; 1 May 2018; 22.01 CET - Galapagos NV (Euronext & NASDAQ: GLPG) and MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) announced today that the first [...]

Dermira to Present at Deutsche Bank 43rd Annual Healthcare Conference

01/05/2018 - 22:02

MENLO PARK, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM ), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]